Proxy firms favour Permira's $751 mln buy of Atrium Innovations

Proxy advisory firms Institutional Shareholder Services Inc and Glass Lewis & Co have recommended that shareholders and convertible debenture holders of natural health products manufacturer Atrium Innovations Inc approve the company's acquisition by an investor group led by European private equity firm Permira Funds for around $751.2 million. The deal, announced in Nov. 2013, will be voted on at a meeting of investors scheduled for January 21st. The Fonds de solidarité des travailleurs du Québec FTQ and Caisse de dépôt et placement du Québec, who collectively hold about 25 percent of the Québec City-based Atrium, have already agreed to vote for the acquisition.

DealsCanadaNorth AmericaBriefs